Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
Corvus Pharmaceuticals, Inc.
SecuraBio
SciTech Development, Inc.
Bristol-Myers Squibb
BeiGene
Celgene
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Progen Pharmaceuticals
Morphotek
INSYS Therapeutics Inc